Novel &lt;i&gt;RAD50&lt;/i&gt; variants lead to Nijmegen Breakage Syndrome-like disorder and unplanned recombinant human growth hormone treatment response. The gene discussed is GH1; the disease is Nijmegen breakage syndrome-like disorder.